Cumberland Operating Income from 2010 to 2024

CPIX Stock  USD 1.40  0.03  2.19%   
Cumberland Pharmaceuticals Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income is likely to outpace its year average in 2024. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Cumberland Pharmaceuticals generates from its operations. View All Fundamentals
 
Operating Income  
First Reported
2006-03-31
Previous Quarter
-1.2 M
Current Value
-1.7 M
Quarterly Volatility
1.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cumberland Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cumberland Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.1 M, Interest Expense of 701.3 K or Selling General Administrative of 8.9 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 0.0 or PTB Ratio of 0.82. Cumberland financial statements analysis is a perfect complement when working with Cumberland Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Cumberland Pharmaceuticals Correlation against competitors.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Latest Cumberland Pharmaceuticals' Operating Income Growth Pattern

Below is the plot of the Operating Income of Cumberland Pharmaceuticals over the last few years. Operating Income is the amount of profit realized from Cumberland Pharmaceuticals operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Cumberland Pharmaceuticals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Cumberland Pharmaceuticals' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cumberland Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Operating Income10 Years Trend
Slightly volatile
   Operating Income   
       Timeline  

Cumberland Operating Income Regression Statistics

Arithmetic Mean(2,400,339)
Coefficient Of Variation(244.57)
Mean Deviation4,644,484
Median(4,081,348)
Standard Deviation5,870,427
Sample Variance34.5T
Range19.1M
R-Value(0.77)
Mean Square Error15.1T
R-Squared0.59
Significance0.0008
Slope(1,011,303)
Total Sum of Squares482.5T

Cumberland Operating Income History

2024-5.9 M
2023-6.2 M
2022-5.7 M
2021-7.7 M
2020-6.4 M
2019-9.3 M
2018-7.4 M

Other Fundumenentals of Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Operating Income component correlations

0.640.87-0.230.390.330.490.430.750.190.660.40.760.22-0.310.270.10.02-0.15-0.01
0.640.53-0.820.85-0.38-0.18-0.420.940.3-0.05-0.410.91-0.30.45-0.540.050.490.510.25
0.870.53-0.10.140.50.510.40.60.110.570.320.680.23-0.470.250.19-0.36-0.39-0.36
-0.23-0.82-0.1-0.850.740.40.7-0.74-0.360.480.64-0.750.52-0.810.730.0-0.65-0.8-0.55
0.390.850.14-0.85-0.63-0.35-0.540.740.43-0.13-0.520.72-0.440.69-0.640.00.810.830.69
0.33-0.380.50.74-0.630.730.84-0.230.00.710.79-0.250.58-0.950.820.33-0.71-0.87-0.65
0.49-0.180.510.4-0.350.730.79-0.020.10.680.70.080.53-0.720.630.16-0.54-0.63-0.3
0.43-0.420.40.7-0.540.840.79-0.22-0.130.840.96-0.170.62-0.890.950.06-0.55-0.79-0.31
0.750.940.6-0.740.74-0.23-0.02-0.220.30.05-0.170.91-0.290.32-0.310.10.430.380.21
0.190.30.11-0.360.430.00.1-0.130.30.05-0.090.2-0.190.18-0.160.830.370.410.32
0.66-0.050.570.48-0.130.710.680.840.050.050.750.090.47-0.770.680.11-0.28-0.53-0.16
0.4-0.410.320.64-0.520.790.70.96-0.17-0.090.75-0.190.6-0.820.970.1-0.44-0.72-0.28
0.760.910.68-0.750.72-0.250.08-0.170.910.20.09-0.19-0.170.28-0.31-0.070.280.320.26
0.22-0.30.230.52-0.440.580.530.62-0.29-0.190.470.6-0.17-0.590.61-0.09-0.4-0.63-0.36
-0.310.45-0.47-0.810.69-0.95-0.72-0.890.320.18-0.77-0.820.28-0.59-0.84-0.170.780.930.66
0.27-0.540.250.73-0.640.820.630.95-0.31-0.160.680.97-0.310.61-0.840.07-0.53-0.79-0.33
0.10.050.190.00.00.330.160.060.10.830.110.1-0.07-0.09-0.170.07-0.020.01-0.18
0.020.49-0.36-0.650.81-0.71-0.54-0.550.430.37-0.28-0.440.28-0.40.78-0.53-0.020.890.78
-0.150.51-0.39-0.80.83-0.87-0.63-0.790.380.41-0.53-0.720.32-0.630.93-0.790.010.890.78
-0.010.25-0.36-0.550.69-0.65-0.3-0.310.210.32-0.16-0.280.26-0.360.66-0.33-0.180.780.78
Click cells to compare fundamentals

About Cumberland Pharmaceuticals Financial Statements

Cumberland Pharmaceuticals investors use historical fundamental indicators, such as Cumberland Pharmaceuticals' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cumberland Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Income-6.2 M-5.9 M
Non Operating Income Net Other86.6 K82.3 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.